The risk of suicidality with selective serotonin reuptake inhibitors
Annals of the Academy of Medicine, Singapore
;
: 96-99, 2006.
Article
in English
| WPRIM
| ID: wpr-300145
ABSTRACT
Antidepressants are efficacious in the treatment of depression but they are not without side effects. The recent findings on the risk of suicide with selective serotonin reuptake inhibitor treatment, however, have raised serious concerns about the risk-benefit ratio of their use. The development of the concerns is traced and the risks discussed, particularly in the child and adolescent group. The prescriber needs to be aware of the issues and of the need for close clinical monitoring of patients started on selective serotonin reuptake inhibitor treatment.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Suicide
/
Age Factors
/
Selective Serotonin Reuptake Inhibitors
/
Risk Assessment
/
Depressive Disorder, Major
/
Diagnosis
Type of study:
Diagnostic study
/
Etiology study
/
Risk factors
Limits:
Adolescent
/
Adult
/
Child
/
Humans
Language:
English
Journal:
Annals of the Academy of Medicine, Singapore
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS